Recombinant Human Tyrosine-protein kinase Mer (MERTK), partial (Active)

(Proto-oncogene c-Mer) (Receptor tyrosine kinase MerTK)

Q12866

21-505aa

C-terminal 10xHis-tagged

Mammalian cell

Homo sapiens (Human)

Pharmacology & Drug Discovery

Less than 1.0 EU/μg as determined by LAL method.

Greater than 95% as determined by SDS-PAGE.

Measured by its binding ability in a functional ELISA. Immobilized MERTK at 2 μg/mL can bind anti-MERTK antibody, the EC50 is 32.95-48.25 ng/mL.

Lyophilized powder

55.4 kDa

For research use only.

Lyophilized from a 0.2 μm filtered 20 mM Tris-HCl, 0.5 M NaCl, 0.2 M Arginine, 6% Trehalose, pH 8.0